questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Hydrolases
Peptide hydrolases
Metalloproteases
Metalloproteases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Metalloproteases : Questions médicales les plus fréquentes",
"headline": "Metalloproteases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Metalloproteases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-14",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Metalloproteases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Peptide hydrolases",
"url": "https://questionsmedicales.fr/mesh/D010447",
"about": {
"@type": "MedicalCondition",
"name": "Peptide hydrolases",
"code": {
"@type": "MedicalCode",
"code": "D010447",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Metalloendopeptidases",
"alternateName": "Metalloendopeptidases",
"url": "https://questionsmedicales.fr/mesh/D008666",
"about": {
"@type": "MedicalCondition",
"name": "Metalloendopeptidases",
"code": {
"@type": "MedicalCode",
"code": "D008666",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Collagenases",
"alternateName": "Collagenases",
"url": "https://questionsmedicales.fr/mesh/D017364",
"about": {
"@type": "MedicalCondition",
"name": "Collagenases",
"code": {
"@type": "MedicalCode",
"code": "D017364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.205"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Microbial collagenase",
"alternateName": "Microbial Collagenase",
"url": "https://questionsmedicales.fr/mesh/D003012",
"about": {
"@type": "MedicalCondition",
"name": "Microbial collagenase",
"code": {
"@type": "MedicalCode",
"code": "D003012",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.205.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Microbial collagenase",
"alternateName": "Microbial Collagenase",
"url": "https://questionsmedicales.fr/mesh/D003012",
"about": {
"@type": "MedicalCondition",
"name": "Microbial collagenase",
"code": {
"@type": "MedicalCode",
"code": "D003012",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.205.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Enzymes de conversion de l'endothéline",
"alternateName": "Endothelin-Converting Enzymes",
"url": "https://questionsmedicales.fr/mesh/D000072396",
"about": {
"@type": "MedicalCondition",
"name": "Enzymes de conversion de l'endothéline",
"code": {
"@type": "MedicalCode",
"code": "D000072396",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.229"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gelatinases",
"alternateName": "Gelatinases",
"url": "https://questionsmedicales.fr/mesh/D018093",
"about": {
"@type": "MedicalCondition",
"name": "Gelatinases",
"code": {
"@type": "MedicalCode",
"code": "D018093",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.252"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Insulinase",
"alternateName": "Insulysin",
"url": "https://questionsmedicales.fr/mesh/D007339",
"about": {
"@type": "MedicalCondition",
"name": "Insulinase",
"code": {
"@type": "MedicalCode",
"code": "D007339",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lysostaphin",
"alternateName": "Lysostaphin",
"url": "https://questionsmedicales.fr/mesh/D008248",
"about": {
"@type": "MedicalCondition",
"name": "Lysostaphin",
"code": {
"@type": "MedicalCode",
"code": "D008248",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.452"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinases",
"alternateName": "Matrix Metalloproteinases",
"url": "https://questionsmedicales.fr/mesh/D020782",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinases",
"code": {
"@type": "MedicalCode",
"code": "D020782",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 14",
"alternateName": "Matrix Metalloproteinase 14",
"url": "https://questionsmedicales.fr/mesh/D053511",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 14",
"code": {
"@type": "MedicalCode",
"code": "D053511",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 15",
"alternateName": "Matrix Metalloproteinase 15",
"url": "https://questionsmedicales.fr/mesh/D053517",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 15",
"code": {
"@type": "MedicalCode",
"code": "D053517",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 16",
"alternateName": "Matrix Metalloproteinase 16",
"url": "https://questionsmedicales.fr/mesh/D053513",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 16",
"code": {
"@type": "MedicalCode",
"code": "D053513",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 14",
"alternateName": "Matrix Metalloproteinase 14",
"url": "https://questionsmedicales.fr/mesh/D053511",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 14",
"code": {
"@type": "MedicalCode",
"code": "D053511",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 15",
"alternateName": "Matrix Metalloproteinase 15",
"url": "https://questionsmedicales.fr/mesh/D053517",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 15",
"code": {
"@type": "MedicalCode",
"code": "D053517",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Matrix metalloproteinase 16",
"alternateName": "Matrix Metalloproteinase 16",
"url": "https://questionsmedicales.fr/mesh/D053513",
"about": {
"@type": "MedicalCondition",
"name": "Matrix metalloproteinase 16",
"code": {
"@type": "MedicalCode",
"code": "D053513",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.525.300.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Procollagen peptidase",
"alternateName": "Procollagen N-Endopeptidase",
"url": "https://questionsmedicales.fr/mesh/D011348",
"about": {
"@type": "MedicalCondition",
"name": "Procollagen peptidase",
"code": {
"@type": "MedicalCode",
"code": "D011348",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.664"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Bacillus thermoproteolyticus neutral proteinase",
"alternateName": "Thermolysin",
"url": "https://questionsmedicales.fr/mesh/D013820",
"about": {
"@type": "MedicalCondition",
"name": "Bacillus thermoproteolyticus neutral proteinase",
"code": {
"@type": "MedicalCode",
"code": "D013820",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.374.827"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Metalloexopeptidases",
"alternateName": "Metalloexopeptidases",
"url": "https://questionsmedicales.fr/mesh/D045727",
"about": {
"@type": "MedicalCondition",
"name": "Metalloexopeptidases",
"code": {
"@type": "MedicalCode",
"code": "D045727",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Carboxypeptidases A",
"alternateName": "Carboxypeptidases A",
"url": "https://questionsmedicales.fr/mesh/D043422",
"about": {
"@type": "MedicalCondition",
"name": "Carboxypeptidases A",
"code": {
"@type": "MedicalCode",
"code": "D043422",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cystinyl aminopeptidase",
"alternateName": "Cystinyl Aminopeptidase",
"url": "https://questionsmedicales.fr/mesh/D010122",
"about": {
"@type": "MedicalCondition",
"name": "Cystinyl aminopeptidase",
"code": {
"@type": "MedicalCode",
"code": "D010122",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glutamate carboxypeptidase II",
"alternateName": "Glutamate Carboxypeptidase II",
"url": "https://questionsmedicales.fr/mesh/D043425",
"about": {
"@type": "MedicalCondition",
"name": "Glutamate carboxypeptidase II",
"code": {
"@type": "MedicalCode",
"code": "D043425",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glutamyl aminopeptidase",
"alternateName": "Glutamyl Aminopeptidase",
"url": "https://questionsmedicales.fr/mesh/D043384",
"about": {
"@type": "MedicalCondition",
"name": "Glutamyl aminopeptidase",
"code": {
"@type": "MedicalCode",
"code": "D043384",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Leucyl Aminopeptidase",
"alternateName": "Leucyl Aminopeptidase",
"url": "https://questionsmedicales.fr/mesh/D007931",
"about": {
"@type": "MedicalCondition",
"name": "Leucyl Aminopeptidase",
"code": {
"@type": "MedicalCode",
"code": "D007931",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lysine carboxypeptidase",
"alternateName": "Lysine Carboxypeptidase",
"url": "https://questionsmedicales.fr/mesh/D001121",
"about": {
"@type": "MedicalCondition",
"name": "Lysine carboxypeptidase",
"code": {
"@type": "MedicalCode",
"code": "D001121",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.656.675.555.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Metalloproteases",
"alternateName": "Metalloproteases",
"code": {
"@type": "MedicalCode",
"code": "D045726",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tania Fontanil",
"url": "https://questionsmedicales.fr/author/Tania%20Fontanil",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain."
}
},
{
"@type": "Person",
"name": "Yamina Mohamedi",
"url": "https://questionsmedicales.fr/author/Yamina%20Mohamedi",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain."
}
},
{
"@type": "Person",
"name": "Teresa Cobo",
"url": "https://questionsmedicales.fr/author/Teresa%20Cobo",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Cirugía y Especialidades Médico-Quirúrgicas, Universidad de Oviedo, 33006 Oviedo, Spain."
}
},
{
"@type": "Person",
"name": "Santiago Cal",
"url": "https://questionsmedicales.fr/author/Santiago%20Cal",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain."
}
},
{
"@type": "Person",
"name": "Álvaro J Obaya",
"url": "https://questionsmedicales.fr/author/%C3%81lvaro%20J%20Obaya",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Biología Funcional, Área de Fisiología, Universidad de Oviedo, 33006 Oviedo, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Developing a nomogram model for 3-month prognosis in patients who had an acute ischaemic stroke after intravenous thrombolysis: a multifactor logistic regression model approach.",
"datePublished": "2024-07-24",
"url": "https://questionsmedicales.fr/article/39053953",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2023-079428"
}
},
{
"@type": "ScholarlyArticle",
"name": "Using a cohort study of diabetes and peripheral artery disease to compare logistic regression and machine learning via random forest modeling.",
"datePublished": "2022-11-23",
"url": "https://questionsmedicales.fr/article/36418976",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12874-022-01774-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "A predictive model to analyze the factors affecting the presence of serious chest injury in the occupants on motor vehicle crashes: Logistic regression approach.",
"datePublished": "2023-07-12",
"url": "https://questionsmedicales.fr/article/37436170",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/15389588.2023.2212392"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development and validation of risk prediction models for large for gestational age infants using logistic regression and two machine learning algorithms.",
"datePublished": "2023-03-08",
"url": "https://questionsmedicales.fr/article/36890429",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1753-0407.13375"
}
},
{
"@type": "ScholarlyArticle",
"name": "Using logistic regression models to investigate the effects of high-sensitivity cardiac troponin T confounders on ruling in acute myocardial infarction.",
"datePublished": "2023-01-26",
"url": "https://questionsmedicales.fr/article/36698327",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1515/cclm-2022-1004"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrolases",
"item": "https://questionsmedicales.fr/mesh/D006867"
},
{
"@type": "ListItem",
"position": 5,
"name": "Peptide hydrolases",
"item": "https://questionsmedicales.fr/mesh/D010447"
},
{
"@type": "ListItem",
"position": 6,
"name": "Metalloproteases",
"item": "https://questionsmedicales.fr/mesh/D045726"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Metalloproteases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Metalloproteases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Metalloproteases",
"description": "Comment diagnostiquer une dysfonction des métalloprotéases ?\nQuels marqueurs sont utilisés pour le diagnostic ?\nLes imageries sont-elles utiles pour le diagnostic ?\nQuels tests génétiques sont disponibles ?\nComment évaluer l'activité enzymatique ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Logistic+Models&page=7#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Metalloproteases",
"description": "Quels symptômes indiquent une surproduction de métalloprotéases ?\nLes symptômes varient-ils selon le type de métalloprotéases ?\nQuels signes cliniques sont associés à une déficience ?\nLes symptômes sont-ils toujours visibles ?\nComment les symptômes évoluent-ils avec l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Logistic+Models&page=7#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Metalloproteases",
"description": "Comment prévenir les maladies liées aux métalloprotéases ?\nLes suppléments nutritionnels sont-ils utiles ?\nL'évitement de certains aliments est-il recommandé ?\nLe contrôle du stress est-il important ?\nLes examens réguliers sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Logistic+Models&page=7#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Metalloproteases",
"description": "Quels traitements ciblent les métalloprotéases ?\nLes thérapies géniques sont-elles une option ?\nComment les anti-inflammatoires aident-ils ?\nLes traitements sont-ils personnalisés ?\nQuels sont les effets secondaires des inhibiteurs ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Logistic+Models&page=7#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Metalloproteases",
"description": "Quelles complications peuvent survenir avec une suractivité ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles prévisibles ?\nQuelles sont les complications liées à une déficience ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Logistic+Models&page=7#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Metalloproteases",
"description": "Quels facteurs augmentent le risque de dysfonction ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe tabagisme est-il un facteur de risque ?\nLe stress chronique influence-t-il le risque ?\nL'exposition à des toxines est-elle un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D045726?mesh_terms=Logistic+Models&page=7#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des métalloprotéases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des biopsies tissulaires peuvent évaluer l'activité des métalloprotéases."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de métalloprotéases dans le sérum ou les tissus peuvent servir de marqueurs diagnostiques."
}
},
{
"@type": "Question",
"name": "Les imageries sont-elles utiles pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'imagerie peut aider à visualiser les tissus affectés par des déséquilibres enzymatiques."
}
},
{
"@type": "Question",
"name": "Quels tests génétiques sont disponibles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent identifier des mutations affectant la production de métalloprotéases."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'activité enzymatique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques spécifiques mesurent l'activité des métalloprotéases dans les échantillons."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surproduction de métalloprotéases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une inflammation, des douleurs articulaires et des lésions tissulaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de métalloprotéases ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, différents types de métalloprotéases peuvent causer des symptômes variés selon les tissus affectés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une déficience ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une cicatrisation lente et des anomalies dans la matrice extracellulaire peuvent être observées."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certaines dysfonctions peuvent être asymptomatiques jusqu'à des stades avancés."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activité des métalloprotéases peut augmenter avec l'âge, aggravant les symptômes dégénératifs."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées aux métalloprotéases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Les suppléments nutritionnels sont-ils utiles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les antioxydants, peuvent soutenir la fonction des métalloprotéases."
}
},
{
"@type": "Question",
"name": "L'évitement de certains aliments est-il recommandé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, réduire les aliments pro-inflammatoires peut aider à réguler l'activité des métalloprotéases."
}
},
{
"@type": "Question",
"name": "Le contrôle du stress est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut influencer l'activité des métalloprotéases, donc sa gestion est cruciale."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers peuvent aider à détecter précocement des déséquilibres enzymatiques."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les métalloprotéases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques des métalloprotéases sont utilisés pour traiter certaines maladies."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques sont-elles une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique peut corriger des mutations affectant la production de métalloprotéases."
}
},
{
"@type": "Question",
"name": "Comment les anti-inflammatoires aident-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent réduire l'inflammation causée par une suractivité des métalloprotéases."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction du type de métalloprotéases impliqué."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des inhibiteurs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inhibiteurs peuvent causer des effets secondaires comme des troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une suractivité ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maladies dégénératives, comme l'arthrite, peuvent résulter d'une suractivité des métalloprotéases."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des douleurs chroniques et une mobilité réduite, affectant la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles en surveillant les niveaux d'activité enzymatique."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications liées à une déficience ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une cicatrisation lente et des infections peuvent survenir en raison d'une déficience en métalloprotéases."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de dysfonction ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, le mode de vie sédentaire et une alimentation déséquilibrée augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies liées aux métalloprotéases peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut exacerber l'activité des métalloprotéases et augmenter les maladies associées."
}
},
{
"@type": "Question",
"name": "Le stress chronique influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber l'équilibre des métalloprotéases, augmentant le risque de maladies."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines environnementales peut affecter l'activité des métalloprotéases."
}
}
]
}
]
}
This study is to establish a nomination graph model for individualised early prediction of the 3-month prognosis of patients who had an acute ischaemic stroke (AIS) receiving intravenous thrombolysis ...
For the period from January 2016 through August 2022, 991 patients who had an acute stroke eligible for intravenous thrombolysis were included in the retrospective analysis study. The study was based ...
Patients who received treatment from January 2016 to February 2021 were included in the training cohort, and those who received treatment from March 2021 to August 2022 were included in the testing co...
Each patient received intravenous thrombolysis within 4.5 hours of onset, with treatment doses divided into standard doses (0.9 mg/kg)....
The primary outcome measure was a 3-month adverse outcome (modified Rankin Scale 3-6)....
The National Institutes of Health Stroke Scale Score after thrombolysis (OR=1.18; 95% CI: 1.04 to 1.36; p = 0.015), door-to-needle time (OR=1.01; 95% CI: 1.00 to 1.02; p = 0.003), baseline blood gluco...
A reliable nomogram model (DGHM2N model) was developed and validated in this study. This nomogram could individually predict the adverse outcome of patients who had an AIS receiving intravenous thromb...
This study illustrates the use of logistic regression and machine learning methods, specifically random forest models, in health services research by analyzing outcomes for a cohort of patients with c...
Cohort study using fee-for-service Medicare beneficiaries in 2015 who were newly diagnosed with peripheral artery disease and diabetes mellitus. Exposure variables include whether patients received pr...
There were 88,898 fee-for-service Medicare beneficiaries diagnosed with peripheral artery disease and diabetes mellitus in our cohort. The rate of preventative treatments in the first six months follo...
The use of random forest models to analyze data and provide predictions for patients holds great potential in identifying modifiable patient-level and health-system factors and cohorts for increased s...
Chest injuries that occur in motor vehicle crashes (MVCs) include rib fractures, pneumothorax, hemothorax, and hemothorax depending on the injury mechanism. Many risk factors are associated with serio...
Among 3,697 patients who visited the emergency room in regional emergency medical centers after MVCs between 2011 and 2018, we analyzed data from 1,226 patients with chest injuries. Vehicle damage was...
Among the 1,226 patients with chest injuries, 484 (39.5%) had serious chest injuries. Patients in the serious group were older than those in the non-serious group (p=.001). In analyses based on vehicl...
Although this study had a major limitation in that the explanatory power of the predictive model was weak due to the small number of samples and many exclusion conditions, it was meaningful in that it...
Large for gestational age (LGA) is one of the adverse outcomes during pregnancy that endangers the life and health of mothers and offspring. We aimed to establish prediction models for LGA at late pre...
Data were obtained from an established Chinese pregnant women cohort of 1285 pregnant women. LGA was diagnosed as >90th percentile of birth weight distribution of Chinese corresponding to gestational ...
A total of 139 newborns were diagnosed as LGA after birth. The area under the curve (AUC) for the training set is 0.760 (95% confidence interval [CI] 0.706-0.815), and 0.748 (95% CI 0.659-0.837) for t...
We established and validated three LGA risk prediction models to screen out the pregnant women with high risk of LGA at the early stage of the third trimester, which showed good prediction power and c...
Confounding factors, including sex, age, and renal dysfunction, affect high-sensitivity cardiac troponin T (hs-cTnT) concentrations and the acute myocardial infarction (AMI) diagnosis. This study asse...
This retrospective study included a primary derivation cohort of 18,022 emergency department (ED) patients at a US medical center and a validation cohort of 890 ED patients at a Canadian medical cente...
The area under the curve of the best-fitted model was 0.95. The model achieved a 90.0% diagnostic accuracy in the validation cohort. The optimal model cutoff yielded comparable performance (90.5% accu...
The integrated prediction model incorporating confounding factors does not outperform hs-cTnT delta thresholds. Sex-specific hs-cTnT delta thresholds remain to provide the highest diagnostic accuracy....
This study aimed to explore the related factors of self-rated health (SRH) by using decision tree and logistic regression models among older adults in rural China....
Convenience sampling was employed with 1,223 enrolled respondents who met the inclusion criteria from 10 randomly selected villages in M County in China. The content of the questionnaire covered demog...
Notably, 817 (68.7%) subjects had good SRH. The logistic regression model showed that living standard, alcohol consumption, sleep quality, labor, hospitalization, discomfort, the number of chronic dis...
Decision tree and logistic regression models complement each other and can describe the factors related to the SRH of the elderly in rural China from different aspects. Our findings indicated that men...
To use the logistic regression model to evaluate the value of ultrasound characteristics in the Ovarian-Adnexal Reporting and Data System ultrasound lexicon in determining ovarian solid component-cont...
We retrospectively analyzed the data of 172 patients with adnexal masses discovered by ultrasound, and diagnosis was confirmed by postoperative pathological tests from January 2019 to December 2021. T...
Of the 172 adnexal tumors, 104 were benign, and 68 were malignant. There were differences in cancer antigen 125, maximum mass diameter, maximum solid component diameter, multilocular cyst with solid c...
The logistic regression model containing the maximum solid component diameter, whether acoustic shadows were present in the solid component, number of papillae, and presence/absence of ascites can hel...
This study aimed to determine the current turnover intention among workers at Centers for Disease Control and Prevention (CDCs) in Northeast China and to investigate the factors contributing to this p...
The cross-sectional study was conducted in May 2023 across four northeastern provinces of China. The study included a total of 11,912 valid participants who were CDC workers selected using a stratifie...
The study found that 28.8% of the respondents reported high turnover intention. The binary logistic regression suggested that the risk factors of turnover intention among employees included gender, ag...
Nearly one-third of the respondents expressed a strong desire to resign from their employment. Turnover intention among CDC workers was subject to diverse influences. Early identification, detection, ...
With childhood hypertension emerging as a global public health concern, understanding its associated factors is crucial. This study investigated the prevalence and associated factors of hypertension a...
Cognitive dysfunction is one of the leading causes of disability and dependence in older adults and is a major economic burden on the public health system. The aim of this study was to investigate the...
A cross-sectional study was conducted using a multistage sampling method. The questionnaires were distributed through the Elderly Disability Monitoring Platform to older adults aged 60 years and above...
A total of 12,494 valid questionnaires were collected, including 2617 from participants in the cognitive dysfunction group and 9877 from participants in the normal cognitive function group. Univariate...
Traditional risk factors (including BMI, literacy, and alcohol consumption) and potentially modifiable risk factors (including balance function, ability to care for oneself in daily life, and widowhoo...